Cytonics Corporation, a clinical-stage biopharmaceutical company developing novel Alpha-2-Macroglobulin (A2M)-based ...

(COLORADO SPRINGS) – Christian Youth Theater (CYT) is getting ready to open its production of ‘Shrek the Musical’ on Friday, May 29. It marks the first of eight performances over two weeks. Ahead of ...

- CYT-0851 has demonstrated broad clinical activity and a generally well tolerated safety profile in a heavily pretreated population of patients - Durable responses seen in both solid tumors and ...

The average one-year price target for Cyteir Therapeutics (NASDAQ:CYT) has been revised to 2.55 / share. This is an increase of 7.14% from the prior estimate of 2.38 dated June 1, 2023. The price ...

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits ...

The average one-year price target for Cyteir Therapeutics (NASDAQ:CYT) has been revised to 3.06 / share. This is an increase of 20.00% from the prior estimate of 2.55 dated October 4, 2023. The price ...

BRISBANE, Australia, Oct. 7, 2025 /PRNewswire/ -- Cyteph Pty Ltd, a biotechnology company developing novel immunotherapies for difficult-to-treat cancers, today announced that it has successfully ...

- CYT-0851 demonstrated activity in combination with capecitabine in heavily pretreated platinum-refractory or -resistant ovarian cancer patients with a generally well tolerated safety profile - ...

Welcome to Christian Youth Theater! Christian Youth Theater (CYT) is an after-school theater arts training program for students ages 4-18. Since its founding in 1980, CYT has grown to be the largest ...

Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today presented results from a ...